The VCIC is now enrolling twenty (20) dogs with perianal fistula(s) for a clinical trial assessing the clinical outcome of dogs with varying degrees of inflammation and irritation due to perianal fistulas. Dogs enrolled will be randomized to a new, one-time injection into the lesion(s) to help manage perianal fistulas and the corresponding symptoms. All patients will also continue to receive standard-of-care therapy (oral cyclosporine), which will be tapered according to patient response. Patients will be require to attend eight (8) visits within 7 months to the University of Pennsylvania Veterinary Hospital.
- Dogs 1-12 years of age
- Confirmed diagnosis of at least one perianal fistula
- Patient must be receiving continued oral cyclosporine for a minimum of 2 weeks prior to enrollment
- No evidence of significant clinical conditions/diseases
- No history of surgical intervention for the treatment of perianal fistula (including but not limited to: cryosurgery, anal sac resection, tail amputation)
- Financial coverage for scheduled study tests, medications, and all study visits
- Financial compensation for time and travel upon completion of all study visits
If interested in enrolling your dog in this study, or would like to learn more, contact the VCIC at 215-573-0302 or email@example.com for more information about this or any of our other studies.